Home \ Mexidol® - how to apply?

Mexidol® - how to use?

Cognitive impairment caused by arterial hypertension: from clinical guidelines to practical algorithms

The brain is a target organ for arterial hypertension: features of management of the elderly patient

Autonomic dysfunction and arterial hypertension: together or instead?

Neuro-ophthalmology in an interdisciplinary context: a dialogue between a neurologist and an ophthalmologist

Attention deficit hyperactivity disorder in the practice of a pediatrician and child neurologist

Post-Stroke Care: What Can a Physician Do?

Key milestones in the treatment of cerebrovascular diseases: a current algorithm

Cerebrovascular and Ocular Diseases: Collaboration Between a Neurologist and an Ophthalmologist

Original and generic drugs: selection criteria, what a pharmacist needs to know

Problems of vascular pathology of the brain in the concept of cerebrometabolic health

Announcement:

Mexidol® is an original drug, that is, an innovator in his international unauthorized name (MNN segment). It is the first time a synthesized active molecule, which has passed a full cycle of preclinical and clinical studies that proved the effectiveness of Mexidol . Mexidol is based on two related and functionally significant compounds: 2-ethyl-6-methyl-3-hydroxypyridine and succinate. The combination of these components determines the multimodal properties and a wide range of pharmacological effects of the drug Mexidol ® .

All video next video

Cognitive impairment caused by arterial hypertension: from clinical guidelines to practical algorithms

The brain is a target organ for arterial hypertension: features of management of the elderly patient

Autonomic dysfunction and arterial hypertension: together or instead?

Neuro-ophthalmology in an interdisciplinary context: a dialogue between a neurologist and an ophthalmologist

Attention deficit hyperactivity disorder in the practice of a pediatrician and child neurologist

Post-Stroke Care: What Can a Physician Do?

Key milestones in the treatment of cerebrovascular diseases: a current algorithm

Cerebrovascular and Ocular Diseases: Collaboration Between a Neurologist and an Ophthalmologist

Original and generic drugs: selection criteria, what a pharmacist needs to know

Problems of vascular pathology of the brain in the concept of cerebrometabolic health

Block of articles on this topic

Original and reproduced drugs: what do the clinician need to know?

Author:
A.V. Schulkin, A.A. Filimonova
FSBEI in the Ryazan State Medical University of the Ministry of Health of Russia, Ryazan, Russia

THE INFORMATION IS INTENDED FOR HEALTHCARE AND PHARMACEUTICAL PROFESSIONALS. THIS INFORMATION IS NOT INTENDED AS A SUBSTITUTE FOR MEDICAL ADVICE.

Source of photos and images Shutterstock.com